Live Breaking News & Updates on Dcgi

Stay informed with the latest breaking news from Dcgi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dcgi and stay connected to the pulse of your community

Drug Controller General of India: New initiative by Drug Controller General of India to boost ease of doing business

The Drug Controller General of India (DCGI) plans to hold walk-in meetings with stakeholders to improve the ease of doing business in India. Starting on February 20, these meetings will take place every Tuesday and Thursday at the CDSCO Headquarters. The DCGI, responsible for drug approval, clinical trials, drug standards, imported drug quality control, and State Drug Control Organization coordination, aims to hear complaints, grievances, and suggestions for swift resolution.

Business-news , Breaking-news , Latest-news-updates , Economic-times , Economic-times-news-app , Daily-market-updates , Live-business , Economic-times-prime , Drug-controller-general-of-india , Dcgi , Walk-in-meetings

Publish monthly list of spurious drugs, DCGI tells state bodies

The document states the draft regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of central and state drug authorities. "This guideline will be useful for effective surveillance for quality and efficacy of drugs and cosmetics by adopting uniform drug sampling methodology for drug inspectors under drug regulatory authorities of state and central," it said.

Business-news , Breaking-newsbudget , Latest-news-updates , Economic-times , Economic-times-news-app , Daily-market-updates , Live-business , Spurious-drugs , Dcgi , Standard-quality , State-bodies

DGGI busts 1,700 fake ITC cases worth Rs. 18,000 crore in Apr-Dec, arrests 98

DGGI has busted 1,700 fake Input Tax Credit (ITC) cases worth Rs 18,000 crore and arrested 98 people. Using data analysis and advanced tools, DGGI apprehended tax evaders involved in creating fake firms and companies. In one case, a firm in Haryana generated E-way bills and created Rs. 1,100 crore fraudulent ITC.

Jaipur , Rajasthan , India , Delhi , Sonipat , Haryana , Uttar-pradesh , Ghaziabad , Chandni-chowk , Haryana-sirsa , Ashutosh-garg ,

'Cannot Export Products Made for Sale in Indian Market': Health Regulator Issues Alert

Products made for the Indian market cannot be exported, the central health regulator has said in an alert issued to all of its port offices across India, asking them to watch the exports by merchant exporters, News18 has learnt.

India , Central-drugs-standard-control-organisation , Drugs-controller-general , India-only , India-market , Indian-product-reputation , Dcgi , Dsco ,

drugs: Export of drugs meant only for Indian market under DCGI lens

The DCGI has asked all port offices to ensure that products meant for the "India market only" are not exported after receiving complaints about the unauthorised export of drugs meant for the local market.

Business-news , Breaking-news-events , Latest-news-updates , Economic-times , Economic-times-news-app , Daily-market-updates , Live-business , Drugs , Export , Indian-market , Pharma

From 'facilitator' to 'regulator': How Rajeev Raghuvanshi is fixing the gaps in pharma industry

The pharmaceutical industry, and the central drug regulatory agency, faced a severe reputation crisis following the deaths of 70 children in Gambia due to contaminated cough syrups in 2022. A few months later, Rajeev Raghuvanshi took over as the Drug Controller General of India and is currently driving a transformational change. Can he set a high bar for product quality?

India , Delhi , Bhawan , Uttar-pradesh , Central-drug-standard-control-organisation , Raghuvanshi , Singh-raghuvanshi , Sun-pharma , Pharma , Dcgi ,

blood banks: Govt says only processing charges to be levied for procuring blood at hospitals, blood banks

The Drugs Controller General of India (DCGI) has issued guidelines directing hospitals and blood banks to charge only processing fees for blood to prevent overcharging. The decision, based on the perspective that "blood is not for sale," was conveyed to states and Union Territory drugs controllers.

India , Drugs-consultative-committee , Drugs-controller-general , Blood-banks , Hospitals , Drugs-controller-general-of-india , Dcgi , Blood , Ut-drug-controllers ,

Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator

Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.

India , Drugs-consultative-committee , Blood-banks , Drug-regulator , Drugs-controller-general , Drugs-controller-general-of-india , Blood-donation , Dcgi ,